BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9930679)

  • 1. Human pancreatic RNase1-human epidermal growth factor fusion: an entirely human 'immunotoxin analog' with cytotoxic properties against squamous cell carcinomas.
    Psarras K; Ueda M; Yamamura T; Ozawa S; Kitajima M; Aiso S; Komatsu S; Seno M
    Protein Eng; 1998 Dec; 11(12):1285-92. PubMed ID: 9930679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor-dependent cytotoxic effect by an EGF-ribonuclease conjugate on human cancer cell lines--a trial for less immunogenic chimeric toxin.
    Jinno H; Ueda M; Ozawa S; Kikuchi K; Ikeda T; Enomoto K; Kitajima M
    Cancer Chemother Pharmacol; 1996; 38(4):303-8. PubMed ID: 8674151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and cytotoxicity of fusion proteins of EGF and angiogenin.
    Yoon JM; Han SH; Kown OB; Kim SH; Park MH; Kim BK
    Life Sci; 1999; 64(16):1435-45. PubMed ID: 10321723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of the growth-inhibitory effect of the RNase-EGF fused protein against EGFR-overexpressing cells.
    Hoshimoto S; Ueda M; Jinno H; Kitajima M; Futami J; Seno M
    Anticancer Res; 2006; 26(2A):857-63. PubMed ID: 16619480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting tumor cells via EGF receptors: selective toxicity of an HBEGF-toxin fusion protein.
    Chandler LA; Sosnowski BA; McDonald JR; Price JE; Aukerman SL; Baird A; Pierce GF; Houston LL
    Int J Cancer; 1998 Sep; 78(1):106-11. PubMed ID: 9724101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor-dependent cytotoxicity for human squamous carcinoma cell lines of a conjugate composed of human EGF and RNase 1.
    Jinno H; Ueda M; Ozawa S; Ikeda T; Enomoto K; Psarras K; Kitajima M; Yamada H; Seno M
    Life Sci; 1996; 58(21):1901-8. PubMed ID: 8637416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting activated lymphocytes with an entirely human immunotoxin analogue: human pancreatic RNase1-human IL-2 fusion.
    Psarras K; Ueda M; Tanabe M; Kitajima M; Aiso S; Komatsu S; Seno M
    Cytokine; 2000 Jun; 12(6):786-90. PubMed ID: 10843765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-level expression and purification of human epidermal growth factor with SUMO fusion in Escherichia coli.
    Su Z; Huang Y; Zhou Q; Wu Z; Wu X; Zheng Q; Ding C; Li X
    Protein Pept Lett; 2006; 13(8):785-92. PubMed ID: 17073723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor-dependent cytotoxic effect of anti-EGFR antibody-ribonuclease conjugate on human cancer cells.
    Suwa T; Ueda M; Jinno H; Ozawa S; Kitagawa Y; Ando N; Kitajima M
    Anticancer Res; 1999; 19(5B):4161-5. PubMed ID: 10628369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Fluorocytosine combined with Fcy-hEGF fusion protein targets EGFR-expressing cancer cells.
    Lan KH; Shih YS; Chang CA; Yen SH; Lan KL
    Biochem Biophys Res Commun; 2012 Nov; 428(2):292-7. PubMed ID: 23085230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human epidermal growth factor and its receptor in esophageal cancer.
    Mukaida H; Yamamoto T; Hirai T; Toi M; Nakamura T; Wada T; Yamashita Y; Kawano K; Niimoto M
    Jpn J Surg; 1990 May; 20(3):275-82. PubMed ID: 2193179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and characterization of recombinant human eosinophil-derived neurotoxin and eosinophil-derived neurotoxin-anti-transferrin receptor sFv.
    Newton DL; Nicholls PJ; Rybak SM; Youle RJ
    J Biol Chem; 1994 Oct; 269(43):26739-45. PubMed ID: 7929408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene amplification and overexpression of epidermal growth factor receptor in squamous cell carcinoma of the head and neck.
    Rikimaru K; Tadokoro K; Yamamoto T; Enomoto S; Tsuchida N
    Head Neck; 1992; 14(1):8-13. PubMed ID: 1624295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of a fusion protein containing human epidermal growth factor and the collagen-binding domain of Vibrio mimicus metalloprotease.
    Kim DG; Min MK; Ahn SC; Kim JK; Kong IS
    Biotechnol Lett; 2009 Feb; 31(2):259-64. PubMed ID: 18931974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
    Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
    J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cytotoxicity of a conjugate composed of human epidermal growth factor and eosinophil cationic protein.
    Jinno H; Ueda M; Ozawa S; Ikeda T; Kitajima M; Maeda T; Seno M
    Anticancer Res; 2002; 22(6C):4141-5. PubMed ID: 12553045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a human epidermal growth factor derivative with EGFR-blocking and depleted biological activities: A comparative in vitro study using EGFR-positive breast cancer cells.
    Mehrabi M; Mansouri K; Soleymani B; Hoseinkhani Z; Shahlaie M; Khodarahmi R
    Int J Biol Macromol; 2017 Oct; 103():275-285. PubMed ID: 28501600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The recombinant anti-EGF receptor immunotoxin 425(scFv)-ETA' suppresses growth of a highly metastatic pancreatic carcinoma cell line.
    Bruell D; Stöcker M; Huhn M; Redding N; Küpper M; Schumacher P; Paetz A; Bruns CJ; Haisma HJ; Fischer R; Finnern R; Barth S
    Int J Oncol; 2003 Oct; 23(4):1179-86. PubMed ID: 12964002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [PTD-hEGF fusion protein--gene expression and function analysis].
    Zhi QW; Wang SH; Zhang FY; Li SG; Sun MJ
    Sheng Wu Gong Cheng Xue Bao; 2007 Jul; 23(4):589-92. PubMed ID: 17822027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An EGF receptor targeting Ranpirnase-diabody fusion protein mediates potent antitumour activity in vitro and in vivo.
    Kiesgen S; Arndt MAE; Körber C; Arnold U; Weber T; Halama N; Keller A; Bötticher B; Schlegelmilch A; Liebers N; Cremer M; Herold-Mende C; Dyckhoff G; Federspil PA; Jensen AD; Jäger D; Kontermann RE; Mier W; Krauss J
    Cancer Lett; 2015 Feb; 357(1):364-373. PubMed ID: 25434798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.